Amgen News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

15.09.14	Amgen: Phase 2 Study Of Romosozumab Shows Increases In Bone Mineral Density (RTTNews)
15.09.14	Amgen Presents Phase 3 Ivabradine Data On Chronic Heart Failure Treatment (RTTNews)
02.09.14	Amgen Submits MAA In Europe For Talimogene Laherparepvec (RTTNews)
02.09.14	Amgen Files MAA To EMA For Investigational Medication Evolocumab (RTTNews)
28.08.14	Amgen Submits BLA For Evolocumab - Quick Facts (RTTNews)
27.08.14	Amgen Gets FDA Priority Review For Heart Drug - Update (RTTNews)
19.08.14	Amgen Says Second Phase 3 Study Of AMG 416 Meets Goals (RTTNews)
14.08.14	Amgen Blood Cancer Drug Fails Primary Endpoint In Late-Stage Study (RTTNews)
13.08.14	Amgen Reports Recall Of Nine Packaged Lots Of Aranesp - Quick Facts (RTTNews)
13.08.14	Amgen Says Phase 3 Focus Trial Fails To Meet Primary Endpoint (RTTNews)
04.08.14	Amgen Blood Cancer Drug Meets Primary Endpoint In Late-Stage Study (RTTNews)
04.08.14	Amgen: Phase 3 Study In Multiple Myeloma Meets Primary Goal (RTTNews)
30.07.14	After-market Movers For July 29 (TWTR, AMGN, ZLTQ, DWA, BWLD) (RTTNews)
29.07.14	Amgen Profit Tops Street, Lifts Outlook; To Cut Up To 2,900 Jobs (RTTNews)
29.07.14	Amgen Q2 Results Top Estimates; To Cut 2,400-2,900 Jobs (RTTNews)
29.07.14	Earnings Watch For July 29 (TWTR, AET, RAI, SIRI, UPS, PNRA, WYNN) (RTTNews)
25.07.14	Bayer, Onyx Pharma Say Phase 3 Trial Of NEXAVAR Fails To Meet Primary Endpoint (RTTNews)
18.07.14	Amgen Reports Positive Phase 3 Results For Thyroid Drug AMG 416 (RTTNews)
01.07.14	Amgen Receives FDA Breakthrough Therapy Status For Blinatumomab In Leukemia (RTTNews)
20.06.14	Bayer: Nexavar Approved In Japan For Treatment Of Thyroid Cancer - Quick Facts (RTTNews)
09.06.14	Amgen Names David Meline CFO - Update (RTTNews)
09.06.14	Amgen Appoints David Meline As EVP, CFO - Quick Facts (RTTNews)
02.06.14	Amgen: Clinical Trials Support Potential Of Talimogene In Metastatic Melanoma (RTTNews)
24.05.14	Amgen's Colon Cancer Drug Vectibix Gets Expanded FDA Approval (RTTNews)
13.05.14	Amgen: Evolocumab In Combination With Statin Therapy Reduces LDL Cholesterol (RTTNews)
09.05.14	Amgen, AstraZeneca Say Ph 3 Study Of Psoriasis Drug Brodalumab Meets Goals (RTTNews)
23.04.14	After-market Movers For April 22 (T, AMGN, YUM, GILD, SWKS, SMCI, ILMN, SKX, CREE, ISRG) (RTTNews)
22.04.14	Amgen Profit Falls 25% (RTTNews)
22.04.14	Amgen Profit Falls Amid Revenue Growth, Misses Estimate - Quick Facts (RTTNews)
22.04.14	Earnings Watch For April 22 (MCD, JNPR, UTX, TRV, AMGN, T, XRX) (RTTNews)
04.04.14	Amgen Updates On Talimogene Laherparepvec Phase 3 Study In Metastatic Melanoma (RTTNews)
30.03.14	Amgen Reports Data From Phase 3 Studies On Evolocumab (RTTNews)
29.03.14	Amgen's New Data Shows Positive Results For Cholesterol Drug Evolocumab (RTTNews)
18.03.14	ATEC Sees Growth, FPRX Gets High-Five, RNA Walks The Talk, RPRX On The Move (RTTNews)
17.03.14	Amgen: Phase 3 TESLA Trial Meets Primary Goal Of LDL Cholesterol Reduction (RTTNews)
14.03.14	Amgen: Talimogene Laherparepvec Reduced Size Of Melanoma Tumors In New Study (RTTNews)
11.03.14	Bayer And Onyx Say Nexavar Fails To Meet Primary Endpoint In Liver Cancer Trial (RTTNews)
05.02.14	Merck Q4 Profit Down 14%, But Matches View; Sees 2014 Earnings In-line (RTTNews)
05.02.14	Merck, Amgen,Incyte And Pfizer To Collaborate On Anti-Cancer Combination Studies (RTTNews)
05.02.14	Amgen, Merck Collaborate To Evaluate Combination Treatment For Advanced Melanoma (RTTNews)
31.01.14	ARAY On The Rise, AERI Catching Eyes, CORT Growing Big, SLXP Gets FDA Date (RTTNews)
31.01.14	Amgen Says Evolocumab Meets Primary Goals In Late-Stage Study (RTTNews)
28.01.14	Amgen Profit Climbs 30% (RTTNews)
28.01.14	Amgen Q4 Results Top Estimates (RTTNews)
28.01.14	Earnings Watch For January 28 (AMGN, T, EA, YHOO, DD, F) (RTTNews)
23.01.14	Amgen Reports Positive Results From Late-stage GAUSS-2 Trial Of Evolocumab (RTTNews)
10.01.14	Amgen Names Michael Kelly Interim CFO After Jonathan Peacock Resigns (RTTNews)
10.01.14	Amgen Announces Resignation Of Jonathan Peacock As CFO (RTTNews)
19.12.13	Amgen Says Phase 3 DESCARTES Trial Meets Primary Endpoint - Quick Facts (RTTNews)
17.12.13	Amgen Reports Positive Top-Line Results From Phase3 MENDEL-2 Trial Of Evolocumab (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

CieFinRichemont	125.85	2.57 %	K V
Sika	232.30	1.84 %	K V
Swiss Re	132.20	1.58 %	K V
Logitech Intl	72.56	1.48 %	K V
ABB	51.02	1.47 %	K V
Nestle	76.60	0.16 %	K V
Sonova Hldg	300.80	0.00 %	K V
Novartis	93.14	-0.14 %	K V
Swisscom	507.00	-0.29 %	K V
Alcon	78.06	-0.41 %	K V

mehr

02.12.24		Handel in New York: Dow Jones präsentiert sich schlussendlich leichter
02.12.24		Handel in New York: Anleger lassen NASDAQ 100 steigen
02.12.24		Börse New York in Rot: Dow Jones schwächelt
02.12.24		Schwacher Wochentag in New York: Dow Jones am Montagmittag leichter
02.12.24		Gewinne in Frankfurt: LUS-DAX steigt zum Handelsende
02.12.24		Freundlicher Handel: DAX klettert zum Handelsende
02.12.24		Freundlicher Handel in Europa: Euro STOXX 50 verbucht schlussendlich Zuschläge
02.12.24		Börse Frankfurt: TecDAX zeigt sich zum Handelsende fester

02.12.24

Handel in New York: Dow Jones präsentiert sich schlussendlich leichter

02.12.24

Handel in New York: Anleger lassen NASDAQ 100 steigen

02.12.24

Börse New York in Rot: Dow Jones schwächelt

02.12.24

Schwacher Wochentag in New York: Dow Jones am Montagmittag leichter

02.12.24

Gewinne in Frankfurt: LUS-DAX steigt zum Handelsende

02.12.24

Freundlicher Handel: DAX klettert zum Handelsende